ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Apr 2026
Jan 2026
Latest Journal Issues
Nuclear Science and Engineering
June 2026
Nuclear Technology
March 2026
Fusion Science and Technology
May 2026
Latest News
DOE selects first companies for nuclear launch pad
The Department of Energy’s Office of Nuclear Energy and the National Reactor Innovation Center have announced their first selections for the Nuclear Energy Launch Pad: three companies developing microreactors and one developing fuel supply.
The four companies—Deployable Energy, General Matter, NuCube Energy, and Radiant Industries—were selected from the initial pool of Reactor Pilot Program and Fuel Line Pilot Program applicants, the two precursor programs to the launch pad.
T. W. Armstrong, H. S. Moran
Nuclear Science and Engineering | Volume 42 | Number 1 | October 1970 | Pages 41-48
Technical Paper | doi.org/10.13182/NSE70-A19325
Articles are hosted by Taylor and Francis Online.
Calculations have been carried out to estimate the absorbed-dose and dose-equivalent rates at various depths in the atmosphere produced by an energetic solar flare—the flare of February 23, 1956. The dose rates are determined both by computing flux spectra using air only and applying flux-to-dose conversion factors and by computing the dose rates in tissue using an air-tissue-air arrangement. The two methods of calculation are in reasonable agreement when the flux-to-dose factors are applied to the forward-flux spectra, but the calculations indicate that previous results obtained using omnidirectional-flux spectra overestimate the dose rates. Also, the effect of the fuel carried by a supersonic aircraft on the dose received by the passengers in the event of a solar flare has been considered and found not to be substantial.